A randomized, double-blind, parallel pharmacokinetic study comparing the trastuzumab biosimilar candidate, AryoTrust®, and reference trastuzumab in healthy subjects - Concepedia

Concepedia

Publication | Closed Access

A randomized, double-blind, parallel pharmacokinetic study comparing the trastuzumab biosimilar candidate, AryoTrust®, and reference trastuzumab in healthy subjects

13

Citations

14

References

2020

Year

Mohammad Farmahini Farahani, Parnian Maghzi, Nazanin Jafari Aryan, Borna Payandemehr, Mayur Soni, Morteza Azhdarzadeh

Expert Opinion on Investigational Drugs

Abstract

The trial is registered at Indian Trials Registry (CTRI/2019/03/018218).

References

	Year	Citations

Page 1